Copyright
©The Author(s) 2024.
World J Gastroenterol. May 14, 2024; 30(18): 2467-2478
Published online May 14, 2024. doi: 10.3748/wjg.v30.i18.2467
Published online May 14, 2024. doi: 10.3748/wjg.v30.i18.2467
Table 1 Characteristics and actions of the medication object of the Delphi consensus, Nux vomica-Heel
Characteristics of Nux vomica-Heel |
Nux vomica-Heel tablets (also marketed as Gastricumeel®, Biologische Heilmittel Heel GmbH, Baden-Baden - Germany) is a natural, multicomponent low dose medication consisting of six ingredients from the homeopathic tradition useful for the treatment of bloating, acid reflux, and other symptoms as well as for heartburn |
Each component of Nux vomica-Heel, according to literature (basic research), exerts a cohort of function |
Nux vomica: Modulation of acid secretion[16-19] |
Pulsatilla: Modulation of mucosal inflammation; modulation of mucosal secretions[21] |
Antimonium crudum: Modulation of mucosal inflammation[22,23] |
Argentum nitricum: Modulation of mucosal inflammation; increased EGF (Epidermal Growth Factor) release[24,25] |
Arsenicum album: Modulation of mucosal inflammation; reduced VEGF (Vasal Endothelial Growth Factor) release[26,27] |
Carbo vegetabilis: Chelation of toxins[28,29] |
According to the composition, three can be the main actions of Nux vomica-Heel: |
(1) Aetiologic, through a direct modulation of acid secretion |
(2) Symptomatic, through the modulation of gastric mucosa acute inflammation |
(3) Preventive, through the modulation of gastric mucosa inflammation progression |
- Citation: Battaglia E, Bertolusso L, Del Prete M, Monzani M, Astegiano M. Overlapping approach Proton Pump Inhibitors/Nux vomica-Heel as new intervention for gastro-esophageal reflux management: Delphi consensus study. World J Gastroenterol 2024; 30(18): 2467-2478
- URL: https://www.wjgnet.com/1007-9327/full/v30/i18/2467.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i18.2467